Clinical presentation and diagnosis of Amyotrophic Lateral Sclerosis

NeuroRehabilitation

Volumn 22, Issue 6, 2007, Pages 409-416

  Ferguson, Toby A ^a   Elman, Lauren B ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b PENNSYLVANIA HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CEREBROSPINAL FLUID ANALYSIS; CLINICAL EXAMINATION; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DYSPHAGIA; ELECTROMYOGRAPHY; HUMAN; IMAGE ANALYSIS; LABORATORY DIAGNOSIS; MOTOR NEURON DISEASE; MUSCLE WEAKNESS; NERVE CELL NECROSIS; NERVE CONDUCTION; RESPIRATORY FAILURE; RISK FACTOR; SENSITIVITY ANALYSIS; VALIDATION PROCESS;

EID: 38049009597     PISSN: 10538135     EISSN: None     Source Type: Journal    
DOI: 10.3233/nre-2007-22602     Document Type: Article

References (31)

1. J.F. Annegers, S. Appel, J.R. Lee and P. Perkins, Incidence and prevalence of amyotrophic lateral sclerosis in Harris County, Texas, 1985-1988, Arch Neurol 48 (1991), 589-593.
2. G. Bensimon, L. Lacomblez and V. Meininger, A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group, N Engl J Med 330 (1994), 585-591.
3. S. Boillee, C. Vande Velde and D.W. Cleveland, ALS: a disease of motor neurons and their nonneuronal neighbors, Neuron 52 (2006), 39-59.
4. B.R. Brooks, El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors, J Neurol Sci 124 Suppl (1994), 96-107.
5. B.R. Brooks, R.G. Miller, M. Swash and T.L. Munsat, El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis, Amyotroph Lateral Scler Other Motor Neuron Disord 1 (2000), 293-299.
6. V. Chaudhry, A.M. Corse, D.R. Cornblath, R.W. Kuncl, M.L. Freimer and J.W. Griffin, Multifocal motor neuropathy: electrodiagnostic features, Muscle Nerve 17 (1994), 198-205.
7. K.R. Chaudhuri, S. Crump, S. al-Sarraj, V. Anderson, J. Cavanagh and P.N. Leigh, The validation of El Escorial criteria for the diagnosis of amyotrophic lateral sclerosis: a clinicopathological study, J Neurol Sci 129 Suppl (1995), 11-12.
8. Y.Z. Chen, C.L. Bennett, H.M. Huynh, I.P. Blair, I. Puls, J. Irobi, I. Dierick, A. Abel, M.L. Kennerson, B.A. Rabin, G.A. Nicholson, M. Auer-Grumbach, K. Wagner, P. De Jonghe, J.W. Griffin, K.H. Fischbeck, V. Timmerman, D.R. Cornblath and P.F. Chance, DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4), Am J Hum Genet 74 (2004), 1128-1135.
9. D.W. Cleveland and J.D. Rothstein, From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS, Nat Rev Neurosci 2 (2001), 806-819.
10. A.J. da Rocha, A.S. Oliveira, R.B. Fonseca, A.C. Maia, Jr., R.P. Buainain and H.M. Lederman, Detection of corticospinal tract compromise in amyotrophic lateral sclerosis with brain MR imaging: relevance of the T1-weighted spin-echo magnetization transfer contrast sequence, AJNR Am J Neuroradiol 25 (2004), 1509-1515.
11. M. de Carvalho and M. Swash, Nerve conduction studies in amyotrophic lateral sclerosis, Muscle Nerve 23 (2000), 344-352.
12. R.B. Forbes, S. Colville and R.J. Swingler, Are the El Escorial and Revised El Escorial criteria for ALS reproducible? A study of inter-observer agreement, Amyotroph Lateral Scler Other Motor Neuron Disord 2 (2001), 135-138.
13. M.J. Greenway, P.M. Andersen, C. Russ, S. Ennis, S. Cashman, C. Donaghy, V. Patterson, R. Swingler, D. Kieran, J. Prehn, K.E. Morrison, A. Green, K.R. Acharya, R.H. Brown, Jr. and O. Hardiman, ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis, Nat Genet 38 (2006), 411-413.
14. R. Gregory, K. Mills and M. Donaghy, Progressive sensory nerve dysfunction in amyotrophic lateral sclerosis: a prospective clinical and neurophysiological study, J Neurol 240 (1993), 309-314.
15. S. Hadano, C.K. Hand, H. Osuga, Y. Yanagisawa, A. Otomo, R.S. Devon, N. Miyamoto, J. Showguchi-Miyata, Y. Okada, R. Singaraja, D.A. Figlewicz, T. Kwiatkowski, B.A. Hosler, T. Sagie, J. Skaug, J. Nasir, R.H. Brown, Jr., S.W. Scherer, G.A. Rouleau, M.R. Hayden and J.E. Ikeda, A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2, Nat Genet 29 (2001), 166-173.
16. R.D. Henderson and J.R. Daube, Decrement in surface-recorded motor unit potentials in amyotrophic lateral sclerosis, Neurology 63 (2004), 1670-1674.
17. P.G. Ince, J. Evans, M. Knopp, G. Forster, H.H. Hamdalla, S.B. Wharton and P.J. Shaw, Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS, Neurology 60 (2003), 1252-1258.
18. S.M. Juergens, L.T. Kurland, H. Okazaki and D.W. Mulder, ALS in Rochester, Minnesota, 1925-1977, Neurology 30 (1980), 463-470.
19. P. Kaufmann, S.L. Pullman, D.C. Shungu, S. Chan, A.P. Hays, M.L. Del Bene, M.A. Dover, M. Vukic, L.P. Rowland and H. Mitsumoto, Objective tests for upper motor neuron involvement in amyotrophic lateral sclerosis (ALS), Neurology 62 (2004), 1753-1757.
20. A.R. La Spada, D.B. Roling, A.E. Harding, C.L. Warner, R. Spiegel, I. Hausmanowa-Petrusewicz, W.C. Yee and K.H. Fischbeck, Meiotic stability and genotype-phenotype correlation of the trinucleotide repeat in X-linked spinal and bulbar muscular atrophy, Nat Genet 2 (1992), 301-304.
21. S. Lefebvre, L. Burglen, S. Reboullet, O. Clermont, P. Burlet, L. Viollet, B. Benichou, C. Cruaud, P. Millasseau, M. Zeviani et al., Identification and characterization of a spinal muscular atrophy-determining gene, Cell 80 (1995), 155-165.
22. R.G. Miller, J.D. Mitchell, M. Lyon and D.H. Moore, Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND), Cochrane Database Syst Rev (2007), CD001447.
23. A.L. Nishimura, M. Mitne-Neto, H.C. Silva, A. Richieri-Costa, S. Middleton, D. Cascio, F. Kok, J.R. Oliveira, T. Gillingwater, J. Webb, P. Skehel and M. Zatz, A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis, Am J Hum Genet 75 (2004), 822-831.
24. G.M. Pasinetti, L.H. Ungar, D.J. Lange, S. Yemul, H. Deng, X. Yuan, R.H. Brown, M.E. Cudkowicz, K. Newhall, E. Peskind, S. Marcus and L. Ho, Identification of potential CSF biomarkers in ALS, Neurology 66 (2006), 1218-1222.
25. C. Pohl, W. Block, F. Traber, S. Schmidt, H. Pels, C. Grothe, H.H. Schild and T. Klockgether, Proton magnetic resonance spectroscopy and transcranial magnetic stimulation for the detection of upper motor neuron degeneration in ALS patients, J Neurol Sci 190 (2001), 21-27.
26. S. Ranganathan, E. Williams, P. Ganchev, V. Gopalakrishnan, D. Lacomis, L. Urbinelli, K. Newhall, M.E. Cudkowicz, R.H. Brown, Jr. and R. Bowser, Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis, J Neurochem 95 (2005), 1461-1471.
27. L.P. Rowland and N.A. Shneider, Amyotrophic lateral sclerosis, N Engl J Med 344 (2001), 1688-1700.
28. J. Suhy, R.G. Miller, R. Rule, N. Schuff, J. Licht, V. Dronsky, D. Gelinas, A.A. Maudsley and M.W. Weiner, Early detection and longitudinal changes in amyotrophic lateral sclerosis by (1)H MRSI, Neurology 58 (2002), 773-779.
29. B.J. Traynor, M.B. Codd, B. Corr, C. Forde, E. Frost and O. Hardiman, Incidence and prevalence of ALS in Ireland, 1995-1997: a population-based study, Neurology 52 (1999), 504-509.
30. S. Wang, H. Poptani, M. Bilello, X. Wu, J.H. Woo, L.B. Elman, L.F. McCluskey, J. Krejza and E.R. Melhem, Diffusion tensor imaging in amyotrophic lateral sclerosis: volumetric analysis of the corticospinal tract, AJNR Am J Neuroradiol 27 (2006), 1234-1238.
31. S. Wang, H. Poptani, J.H. Woo, L.M. Desiderio, L.B. Elman, L.F. McCluskey, J. Krejza and E.R. Melhem, Amyotrophic lateral sclerosis: diffusion-tensor and chemical shift MR imaging at 3.0 T, Radiology 239 (2006), 831-838.